Icotinib enhances lung cancer cell radiosensitivity in vitro and in vivo by inhibiting MAPK/ERK and AKT activation.

scientific article

Icotinib enhances lung cancer cell radiosensitivity in vitro and in vivo by inhibiting MAPK/ERK and AKT activation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1440-1681.12966
P698PubMed publication ID29770473

P50authorSen ZhangQ93055416
P2093author name stringSen Zhang
Jing Wang
Dongjie Wang
P577publication date2018-05-16
P1433published inClinical and Experimental Pharmacology and PhysiologyQ5133807
P1476titleIcotinib enhances lung cancer cell radiosensitivity in vitro and in vivo by inhibiting MAPK/ERK and AKT activation.

Reverse relations

cites work (P2860)
Q89450215A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer
Q59789600Icotinib inhibits the proliferation of hepatocellular carcinoma cells in vitro and in vivo dependently on EGFR activation and PDL1 expression
Q94545748NGAL protects in nasopharyngeal carcinoma by inducing apoptosis and blocking epithelial-mesenchymal transition
Q64979315Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study.
Q60921827miR-181a/b therapy in lung cancer: reality or myth?